Molina Healthcare, Inc. (MOH)
273.06 USD -13.36 (-4.66%) Volume: 0.93M
Molina Healthcare, Inc.’s stock price stands at 273.06 USD, experiencing a dip of -4.66% this trading session with a trading volume of 0.93M, reflecting a YTD percentage change of -6.18%, showcasing the volatility and potential investment opportunities in the healthcare sector.
Latest developments on Molina Healthcare, Inc.
Recent events have seen Molina Healthcare, Inc. (MOH) making waves in the stock market. Despite underperforming compared to competitors, Cambiar Investors LLC has shown confidence with a $9.64 million stake in the company. Cantor Fitzgerald’s price target for Molina Healthcare has been adjusted from $406 to $356. However, TD Cowen maintains a buy rating and has adjusted the price target to $342. Empirical Finance LLC has also boosted its stake in the company. Despite missing estimates in their recent earnings results, Molina Healthcare is predicted for strategic growth amidst challenges, with a buy rating and a potential soar in 2025. With various stakeholders adjusting their positions and price targets, the future looks promising for Molina Healthcare.
Molina Healthcare, Inc. on Smartkarma
Analysts on Smartkarma are bullish on Molina Healthcare, a company that operates in the Managed Medicaid market. According to Value Investors Club, Molina Healthcare‘s successful business model effectively manages Medicaid programs while minimizing risk for state administrators. This advantage comes from operating in a competitive landscape with few key players, giving them an edge when states put their programs out to bid. The article also highlights the company’s fixed fee per member in exchange for assuming medical risk and managing provider networks.
Baptista Research also published a report on Molina Healthcare, focusing on the company’s recent financial performance. Despite facing challenges such as upward pressure on medical costs, Molina Healthcare reported adjusted earnings per share of $6.01 for the third quarter of 2024. The company maintained a robust adjusted pre-tax margin of 4.5%, demonstrating a balanced business portfolio. Analysts point out that certain financial achievements offset ongoing challenges for Molina Healthcare, reflecting a mixed performance in the latest earnings report.
A look at Molina Healthcare, Inc. Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 1 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
According to Smartkarma Smart Scores, Molina Healthcare has a positive long-term outlook. With high scores in Growth and Resilience, the company is positioned for future success. Molina Healthcare‘s focus on expanding its health plans and primary care clinics indicates a strong potential for growth in the coming years.
Despite a lower score in Dividend, Molina Healthcare‘s overall outlook remains promising. The company’s emphasis on providing healthcare services to low-income families and individuals through Medicaid programs showcases its commitment to serving the community. With a solid foundation in place, Molina Healthcare is well-positioned to continue its positive trajectory in the managed care organization sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
